Spine Biologics Market: Can "Designer Cells" End the Need for Traditional Metal Implants?
In 2026, the global Spine Biologics Market is undergoing a monumental shift from mechanical stabilization to biological regeneration. This year, the industry is moving beyond simple bone grafts toward "Genetically Programmed Stem Cells" that are designed to regrow damaged intervertebral discs from the inside out. These bio-active treatments are effectively reducing the reliance on titanium rods...
0 Commenti 0 condivisioni 12 Views 0 Anteprima